Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287412 · ClinicalTrials.gov registry record
Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children
A clinical trial of Multisystem Inflammatory Syndrome in Children (MIS-C), sponsored by Carelon Research.
- Active
- Registry status
- 1,200
- Enrollment target
- 20
- Study locations
NCT05287412: Active study of Multisystem Inflammatory Syndrome in Children (MIS-C), sponsored by Carelon Research.
NCT05287412 is a study of Multisystem Inflammatory Syndrome in Children (MIS-C) that is active but no longer recruiting, run by Carelon Research. The registered enrollment target is 1,200 participants. The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287412, a study of Multisystem Inflammatory Syndrome in Children (MIS-C), is active but no longer recruiting, sponsored by Carelon Research.
- ACTIVE NOT RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 20
- Study locations
Study Summary
Multi-system Inflammatory Syndrome in Children (MIS-C) is a new condition related to COVID-19, the study investigators are still learning about its causes, effects, and long-term impact. "Long-Term Outcomes after the Multisystem Inflammatory Syndrome In Children", the Coronavirus MUSIC Study, is a research study funded by NIH and the National Heart, Lung, and Blood Institute. The study investigators hope to enroll at least 900 young people with MIS-C at children's medical centers in the U.S. and Canada. This research study will help us learn more about MIS-C and its effects on the long-term health of children.
Primary Outcome
worst left ventricular (LV) ejection fraction from core lab echo read during MUSIC study
Conditions Studied
Study Locations (20)
California
- Children's Hospital Los Angeles - Los Angeles
- Valley Children's Healthcare and Hospital - Madera
- UC San Diego, Rady Children's Hospital - San Diego
Florida
- Joe DiMaggio Children's Hospital - Hollywood
- Nicklaus Children's Hospital - Miami
Michigan
- CS Mott Children's Hospital/University of Michigan - Ann Arbor
- Children's Hospital of Michigan - Detroit
Alabama
- University of Alabama - Tuscaloosa
Arizona
- Phoenix Children's Hospital - Phoenix
Colorado
- Children's Hospital of Colorado - Aurora
Delaware
- The Nemours Foundation - Wilmington
District of Columbia
- Children's National Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2020-09-30 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT05287412 still lists
NCT05287412 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Multisystem Inflammatory Syndrome in Children (MIS-C) appearing as the primary indexed condition, and to 0 interventions.
NCT05287412 names 20 study sites across 16 states, led by California, Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT05287412 about?
NCT05287412 is a clinical study titled "Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children". Multi-system Inflammatory Syndrome in Children (MIS-C) is a new condition related to COVID-19, the study investigators are still learning about its causes, effects, and long-term impact. "Long-Term Outcomes after the Multisystem Inflammatory Syndrome In Children", the Coronavirus MUSIC Study, is a r...
What is the current status of trial NCT05287412?
This trial is currently active not recruiting. The enrollment target is 1,200 participants. The study started on 2020-09-30. Estimated completion is 2025-12-31.
What conditions does trial NCT05287412 study?
This clinical trial studies the following conditions: Multisystem Inflammatory Syndrome in Children (MIS-C).
Who is sponsoring clinical trial NCT05287412?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287412 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multisystem Inflammatory Syndrome in Children (MIS-C)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI